Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Sagent Pharm Inc (SGNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2011	03-2011	12-2010	09-2010	06-2010
Assets
Current Assets
Cash & Cash Equivalents	78,677	32,503	34,584	N/A	N/A
Marketable Securities	49,235	N/A	N/A	N/A	N/A
Receivables	21,600	19,916	18,939	N/A	N/A
Inventories	31,689	31,439	30,567	N/A	N/A
Income taxes - deferred	N/A	6	N/A	N/A	N/A
Other current assets	206	527	868	0	0
TOTAL	$186,146	$91,041	$90,393	$N/A	$N/A

Non-Current Assets
PPE Net	788	737	785	N/A	N/A
Investments And Advances	22,970	23,384	24,466	0	0
Intangibles	3,031	2,579	2,613	0	0
Other Non-Current Assets	948	922	332	0	0
TOTAL	$27,737	$27,622	$28,196	$N/A	$N/A

Total Assets	$213,883	$118,663	$118,589	$N/A	$N/A

Liabilities
Current Liabilities
Short Term Debt	6,818	4,773	N/A	N/A	N/A
Accounts payable and accrued liabilities	15,110	14,914	24,449	0	0
Accrued Expenses	7,626	7,955	8,517	N/A	N/A
Other current liabilities	1,892	3,794	3,926	N/A	N/A
TOTAL	$51,554	$50,174	$57,618	$N/A	$N/A

Non-Current Liabilities
Long Term Debt	8,182	10,227	N/A	N/A	N/A
Other Non-Current Liabilities	606	158,374	157,780	0	0
TOTAL	$8,788	$168,607	$157,780	$N/A	$N/A

Total Liabilities	$60,342	$218,781	$215,398	$N/A	$N/A

Shareholders' Equity
Shares Outstanding, K	27,872	27,828	N/A	N/A	N/A
Common Shares	279	N/A	N/A	N/A	N/A
Retained earnings	-112,978	-104,783	-100,412	N/A	N/A
Other shareholders' equity	1,755	1,529	1,285	0	0
TOTAL	$153,541	$-100,118	$-96,809	$N/A	$N/A

Total Liabilities And Equity	$213,883	$118,663	$118,589	$0	$0